A Study of DTC in Patients With AIDS and AIDS Related Complex
Launched by MERIEUX INSTITUTE · Aug 30, 2001
Trial Information
Current as of March 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- Concurrent Medication:
- Allowed:
- • Zidovudine (AZT).
- • Exclusion Criteria
- Co-existing Condition:
- Patients with the following are excluded:
- • Active opportunistic infection or progressive Kaposi's sarcoma (KS).
- • Dementia.
- • Lymphoma.
- Concurrent Medication:
- Excluded within 3 weeks of study entry:
- • Other experimental AIDS therapy.
- Patients with the following are excluded:
- • Active opportunistic infection or progressive Kaposi's sarcoma (KS).
- • Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and have life expectancy of at least 6 months.
About Merieux Institute
Mérieux Institute is a leading global sponsor of clinical trials, dedicated to advancing public health through innovative research and development in the fields of infectious diseases, vaccines, and diagnostics. With a strong commitment to scientific excellence and collaboration, Mérieux Institute leverages its extensive expertise and resources to conduct high-quality clinical studies that aim to improve healthcare outcomes worldwide. By fostering partnerships with academic institutions, healthcare organizations, and industry leaders, the institute plays a pivotal role in translating scientific discoveries into effective medical solutions, ultimately enhancing patient care and promoting global health security.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Key West, Florida, United States
Durham, North Carolina, United States
San Francisco, California, United States
Los Angeles, California, United States
Brooklyn, New York, United States
Tucson, Arizona, United States
Sherman Oaks, California, United States
Houston, Texas, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials